Jul 16, 2013 9:17am EDT OPKO Health Announces Appointment of David Okrongly, Ph.D. as President of its Diagnostics Business Unit
May 23, 2013 9:32am EDT OPKO Surpasses 50% Enrollment in First Phase 3 Trial of RayaldyTM (CTAP101 Capsules)
Apr 05, 2013 11:45am EDT OPKO Health Announces Publication of Study Detecting Antibodies in NMO Patients Using OPKO Screening Technology